Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production ...

The Cleveland-based health system does not shy away from taking time to ensure that an AI tool is a good investment and is the right solution for its patient population. When it comes to AI tool ...

Beta-CORRECT study to be presented at ASCO 2025 confirms the clinical utility of the molecular residual disease (MRD) test, Oncodetect™, for recurrence monitoring in stage II–IV colorectal cancer ...

Officially unveiled at the American Society of Human Genetics (ASHG) 2025 meeting held in Boston, Genomics has launched Mystra, an AI-enabled human genetics platform designed to accelerate drug target ...

Health systems and their technology vendors can work together to modernize clinical process maps using artificial intelligence – transforming them from static reference documents into living guidance ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Artificial intelligence (AI) company Opyl (ASX:OPL) has entered into a non-exclusive partnership with Phenix Health’s Compendium platform to validate clinic trials associated with cannabis products.